Pfizer Investigational Site is a clinical research site located in Corpus Christi, Texas, United States 78413.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Pfizer Investigational Site has participated in 16 clinical trials.
Therapeutic areas: Diabetic Retinopathy, Diabetes Complications, Diabetes Mellitus.
Sponsors: Quark Pharmaceuticals, Pfizer, Pfizer's Upjohn has merged with Mylan to form Viatris Inc..
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Pfizer Investigational Site has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pfizer Investigational Site has 16 clinical trials on record. Their work covers Diabetic Retinopathy, Diabetes Complications, Diabetes Mellitus.
Yes — Pfizer Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.